跳到正文
Enrique Grande· @drenriquegrande · X·· 2 天前评分90

#BLADDERCANCER

正文 · 原文

Is this the end of platinum-based chemo + immunotherapy in #bladdercancer? 🤔 What should we do with NIAGARA from now on? 😬
@OncoAlert @myESMO @OncoDailyGU
#ESMO26

2526 浏览 · 33 赞 · 13 转发 · 1 回复

帖内回复
  1. Shilpa Gupta@shilpaonc

    @drenriquegrande @OncoAlert @myESMO @OncoDailyGU NIAGARA is still a valid option where EV-P access is an issue and has more data in variant histologies imo

来源:Enrique Grande · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org